ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 647,20
1,02%
Dow Jones
38 834,86
0,00%
DAX
18 163,47
0,53%
Brent Oil
84,745
0,06%
Bitcoin
66 175,77
1,86%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Fibrocell Science Inc (FCSC)

  7. Fibrocell Science Inc (FCSC) Actualités

FCSC

Fibrocell Science (FCSC)

Fibrocell Science Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FCSC
DateHeureSourceTitreSymboleSociété
07/01/202016h30Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:FCSCFibrocell Science Inc
18/12/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FCSCFibrocell Science Inc
17/12/201923h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FCSCFibrocell Science Inc
13/12/201922h07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FCSCFibrocell Science Inc
13/12/201922h04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FCSCFibrocell Science Inc
13/12/201915h41Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FCSCFibrocell Science Inc
13/12/201915h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FCSCFibrocell Science Inc
22/11/201912h01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FCSCFibrocell Science Inc
14/11/201922h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FCSCFibrocell Science Inc
28/10/201921h04Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:FCSCFibrocell Science Inc
26/10/201900h00PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Fibrocell Science, Inc.NASDAQ:FCSCFibrocell Science Inc
11/10/201922h52Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:FCSCFibrocell Science Inc
25/09/201922h33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FCSCFibrocell Science Inc
17/09/201922h34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FCSCFibrocell Science Inc
13/09/201900h35PR Newswire (US)Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire FibrocellNASDAQ:FCSCFibrocell Science Inc
12/09/201923h40GlobeNewswire Inc.Castle Creek Pharmaceutical Holdings to Acquire FibrocellNASDAQ:FCSCFibrocell Science Inc
29/08/201922h53Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FCSCFibrocell Science Inc
14/08/201922h45GlobeNewswire Inc.Fibrocell Reports Second Quarter 2019 Financial Results and Recent Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
30/05/201914h00GlobeNewswire Inc.Fibrocell to Present at BIO International Convention 2019NASDAQ:FCSCFibrocell Science Inc
29/05/201914h00GlobeNewswire Inc.Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEBNASDAQ:FCSCFibrocell Science Inc
15/05/201913h30GlobeNewswire Inc.Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational HighlightsNASDAQ:FCSCFibrocell Science Inc
09/05/201914h00GlobeNewswire Inc.Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and ...NASDAQ:FCSCFibrocell Science Inc
29/04/201922h22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FCSCFibrocell Science Inc
15/04/201912h30GlobeNewswire Inc.Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene TherapyNASDAQ:FCSCFibrocell Science Inc
03/04/201914h00GlobeNewswire Inc.Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate DirectorsNASDAQ:FCSCFibrocell Science Inc
27/03/201921h40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FCSCFibrocell Science Inc
27/03/201912h30GlobeNewswire Inc.Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-00...NASDAQ:FCSCFibrocell Science Inc
20/03/201913h00GlobeNewswire Inc.Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019NASDAQ:FCSCFibrocell Science Inc
14/02/201920h20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FCSCFibrocell Science Inc
06/02/201914h00GlobeNewswire Inc.Fibrocell to Present at 21st Annual BIO CEO & Investor ConferenceNASDAQ:FCSCFibrocell Science Inc
 Showing the most relevant articles for your search:NASDAQ:FCSC

Dernières Valeurs Consultées

ASX
BHPJOZ
USOTC
FNTTD
XR Immersive Tech (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés